TSX:OGIPharmaceuticals
Organigram (TSX:OGI) One‑Off Gain‑Driven Profitability Tests Bullish Narratives on Earnings Durability
Organigram Global (TSX:OGI) has just posted its FY 2025 numbers, with fourth quarter revenue at about CA$80.1 million and basic EPS of roughly ‑CA$0.28. This caps a volatile year that saw both sharp profit and loss swings. Over the last six quarters, revenue has moved from CA$44.7 million in Q4 2024 to CA$80.1 million in Q4 2025, while quarterly basic EPS has ranged from ‑CA$0.20 to CA$0.33. This highlights how sensitive margins remain to one off items and shifting demand. Overall, the latest...